Literature DB >> 2507317

Altered regulation of MHC class I genes in different tumor cell lines is reflected by distinct sets of DNase I hypersensitive sites.

U Maschek1, W Pülm, G J Hämmerling.   

Abstract

MHC class I antigens play a crucial role in immunological functions, e.g. transplant and tumor rejection and antigen presentation. Whereas class I antigens are normally expressed on most adult tissues, albeit in varying amounts, embryonic as well as many tumor cells are characterized by the absence of major histocompatibility complex class I antigens on their cell surfaces. In this study the mechanism controlling the lack of class I expression was analyzed at the level of the chromatin structure. Five DNase I hypersensitive sites were determined at the H-2 D-locus of cell lines constitutively expressing class I genes. Two of them (DH1, located at the TATA box/transcription start site, and DH2, located at the enhancer/interferon response sequence) were absent in the fibrosarcoma IC9 in which expression of the silent Dk class I gene was not inducible. DH1 and DH2 remained absent even after fusion with class-I-positive cells. However, transfected Dk genes were expressed in IC9, and both DH1 and DH2, which were probably derived from the transfected gene, became detectable. In tumor cells expressing class I genes only after treatment with IFN-gamma (e.g. the lung carcinoma CMT64.5) or after in vitro differentiation (F9 embryonal carcinoma cells), DH1 and DH2 were already present before induction of class I expression. However, the intensity of the band indicative of DH2 was reduced in undifferentiated and differentiated F9 cells and in untreated CMT cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507317      PMCID: PMC401162          DOI: 10.1002/j.1460-2075.1989.tb08356.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

Review 2.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

Review 4.  X-chromosome inactivation and developmental patterns in mammals.

Authors:  M F Lyon
Journal:  Biol Rev Camb Philos Soc       Date:  1972-01

Review 5.  Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice.

Authors:  H Lemke; G J Hämmerling; U Hämmerling
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

6.  Letter: Absence of serologically detectable H-2 on primitive teratocarcinoma cells in culture.

Authors:  K Artzt; F Jacob
Journal:  Transplantation       Date:  1974-06       Impact factor: 4.939

7.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Metastasizing tumors from serum-supplemented and serum-free cell lines from a C57BL mouse lung tumor.

Authors:  L M Franks; A W Carbonell; V J Hemmings; P N Riddle
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

9.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.

Authors:  D Plaksin; C Gelber; M Feldman; L Eisenbach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  7 in total

1.  A 47-kDa human nuclear protein recognized by antikinetochore autoimmune sera is homologous with the protein encoded by RCC1, a gene implicated in onset of chromosome condensation.

Authors:  F R Bischoff; G Maier; G Tilz; H Ponstingl
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Impairment of MHC class I transcription in a mutant bovine B cell line.

Authors:  J S Harms; G A Splitter
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues.

Authors:  A Dey; A M Thornton; M Lonergan; S M Weissman; J W Chamberlain; K Ozato
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

4.  DNase I hypersensitive sites flank the mouse class II major histocompatibility complex during B cell development.

Authors:  S Carson
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

5.  The mouse M-lysozyme gene domain: identification of myeloid and differentiation specific DNasel hypersensitive sites and of a 3'-cis acting regulatory element.

Authors:  B Möllers; S Klages; A Wedel; M Cross; E Spooncer; T M Dexter; R Renkawitz
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

6.  A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes.

Authors:  U Henseling; W Schmidt; H R Schöler; P Gruss; A K Hatzopoulos
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  Identification of interacting transcription factors regulating tissue gene expression in human.

Authors:  Zihua Hu; Steven M Gallo
Journal:  BMC Genomics       Date:  2010-01-19       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.